{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T17:06:38Z","timestamp":1781888798806,"version":"3.54.5"},"reference-count":122,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1097\/ppo.0b013e31826246dc","type":"journal-article","created":{"date-parts":[[2012,7,27]],"date-time":"2012-07-27T21:05:47Z","timestamp":1343423147000},"page":"355-363","source":"Crossref","is-referenced-by-count":59,"title":["Genetic Testing by Cancer Site"],"prefix":"10.1097","volume":"18","author":[{"given":"Nicki","family":"Chun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210203","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","article-title":"The two histological main types of gastric carcinoma: diffuse and so-called Intestinal-type carcinoma. An attempt at a histo-clinical classification.","volume":"64","author":"Lauren","year":"1965","journal-title":"Acta Pathol Microbiol Scand"},{"key":"R2-12-20210203","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0344-0338(11)80878-2","article-title":"New elements for an updated classification of the carcinomas of the stomach.","volume":"191","author":"Carneiro","year":"1995","journal-title":"Pathol Res Pract"},{"key":"R3-12-20210203","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1158\/1055-9965.EPI-09-0250","article-title":". Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site.","volume":"18","author":"Wu","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R4-12-20210203","first-page":"459","article-title":". E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas.","volume":"79","author":"Machado","year":"1999","journal-title":"Lab Invest"},{"key":"R5-12-20210203","first-page":"3845","article-title":". E-cadherin gene mutations provide clues to diffuse type gastric carcinomas.","volume":"54","author":"Becker","year":"1994","journal-title":"Cancer Res"},{"key":"R6-12-20210203","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1349-7006.1996.tb03125.x","article-title":". Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines.","volume":"87","author":"Tamura","year":"1996","journal-title":"Jpn J Cancer Res"},{"key":"R7-12-20210203","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1349-7006.1996.tb02109.x","article-title":". E-cadherin gene mutations in signet ring cell carcinoma of the stomach.","volume":"87","author":"Muta","year":"1996","journal-title":"Jpn J Cancer Res"},{"key":"R8-12-20210203","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2559.1994.tb01288.x","article-title":". T (Thomsen-Friedenreich) antigen and other simple mucin-type carbohydrate antigens in precursor lesions of gastric carcinoma.","volume":"24","author":"Carneiro","year":"1994","journal-title":"Histopathology"},{"key":"R9-12-20210203","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000321703","article-title":"Molecular pathology of gastric carcinoma.","volume":"78","author":"Jang","year":"2011","journal-title":"Pathobiology"},{"key":"R10-12-20210203","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ng.982","article-title":". Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer.","volume":"43","author":"Wang","year":"2011","journal-title":"Nat Genet"},{"key":"R11-12-20210203","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/ng.2246","article-title":". Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes.","volume":"44","author":"Zang","year":"2012","journal-title":"Nat Genet"},{"key":"R12-12-20210203","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10689-008-9231-7","article-title":". Evidence of tumor microsatellite instability in gastric cancer with familial aggregation.","volume":"8","author":"Pedrazzani","year":"2009","journal-title":"Fam Cancer"},{"key":"R13-12-20210203","first-page":"5415","article-title":". Red meat, family history, and increased risk of gastric cancer with microsatellite instability.","volume":"61","author":"Palli","year":"2001","journal-title":"Cancer Res"},{"key":"R14-12-20210203","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1146\/annurev.genet.33.1.533","article-title":". Mammalian DNA mismatch repair.","volume":"33","author":"Buermeyer","year":"1999","journal-title":"Annu Rev Genet"},{"key":"R15-12-20210203","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/030089160909500103","article-title":". Smoking status and gastric cancer risk: an updated meta-analysis of case-control studies published in the past ten years.","volume":"95","author":"La Torre","year":"2009","journal-title":"Tumori"},{"key":"R16-12-20210203","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ijc.2910250402","article-title":". Patterns of gastro-intestinal cancer in European migrants to Australia: the role of dietary change.","volume":"25","author":"McMichael","year":"1980","journal-title":"Int J Cancer"},{"key":"R17-12-20210203","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM199110173251604","article-title":". Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii.","volume":"325","author":"Nomura","year":"1991","journal-title":"N Engl J Med"},{"key":"R18-12-20210203","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1056\/NEJM199110173251603","article-title":". Helicobacter pylori infection and the risk of gastric carcinoma.","volume":"325","author":"Parsonnet","year":"1991","journal-title":"N Engl J Med"},{"key":"R19-12-20210203","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/gut.49.3.347","article-title":"Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts.","volume":"49","year":"2001","journal-title":"Gut"},{"key":"R20-12-20210203","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10552-010-9707-2","article-title":". Helicobacter pylori infection and gastric cardia cancer: systematic review and meta-analysis.","volume":"22","author":"Cavaleiro-Pinto","year":"2011","journal-title":"Cancer Causes Control"},{"key":"R21-12-20210203","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/MCG.0b013e318249c4b8","article-title":". Epstein-Barr virus-associated gastric carcinoma: a newly defined entity.","volume":"46","author":"Chen","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"R22-12-20210203","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":". Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.","volume":"127","author":"Ferlay","year":"2008","journal-title":"Int J Cancer"},{"key":"R23-12-20210203","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":". Cancer statistics, 2008.","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"R24-12-20210203","first-page":"1217","article-title":"Is gastric cancer preventable Gut.","volume":"53","author":"Correa","year":"2004","journal-title":""},{"key":"R25-12-20210203","doi-asserted-by":"crossref","first-page":"765","DOI":"10.5858\/2004-128-765-DTITIA","article-title":". Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type.","volume":"128","author":"Henson","year":"2004","journal-title":"Arch Pathol Lab Med"},{"key":"R26-12-20210203","first-page":"1480","article-title":". Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood.","volume":"92","author":"Roosendaal","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"R27-12-20210203","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1046\/j.1365-2168.2000.01425.x","article-title":". Changing pattern of histological type, location, stage and outcome of surgical treatment of gastric carcinoma.","volume":"87","author":"Borch","year":"2000","journal-title":"Br J Surg"},{"key":"R28-12-20210203","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/106689690601400105","article-title":"Genetics, pathology, and clinics of familial gastric cancer.","volume":"14","author":"Oliveira","year":"2006","journal-title":"Int J Surg Pathol"},{"key":"R29-12-20210203","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/ijc.11478","article-title":"Swedish empiric risks: familial risk of cancer: data for clinical counseling and cancer genetics.","volume":"108","author":"Hemminki","year":"2004","journal-title":"Int J Cancer"},{"key":"R30-12-20210203","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1097\/MCG.0b013e3181a159c4","article-title":". Stomach cancer risk in gastric cancer relatives: interaction between Helicobacter pylori infection and family history of gastric cancer for the risk of stomach cancer.","volume":"44","author":"Shin","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"R31-12-20210203","first-page":"286","article-title":". Significant prognostic factors in patients with early gastric cancer.","volume":"85","author":"Yokota","year":"2000","journal-title":"Int Surg"},{"key":"R32-12-20210203","first-page":"873","article-title":". Familial gastric cancer: overview and guidelines for management.","volume":"36","author":"Caldas","year":"1999","journal-title":"J Med Genet"},{"key":"R33-12-20210203","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/32918","article-title":". E-cadherin germline mutations in familial gastric cancer.","volume":"392","author":"Guilford","year":"1998","journal-title":"Nature"},{"key":"R34-12-20210203","first-page":"4086","article-title":". Identification of germ-line E-cadherin mutations in gastric cancer families of European origin.","volume":"58","author":"Gayther","year":"1998","journal-title":"Cancer Res"},{"key":"R35-12-20210203","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1098-1004(1999)14:3<249::AID-HUMU8>3.0.CO;2-9","article-title":". E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer.","volume":"14","author":"Guilford","year":"1999","journal-title":"Hum Mutat"},{"key":"R36-12-20210203","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0002-9440(10)65129-2","article-title":". Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation.","volume":"155","author":"Keller","year":"1999","journal-title":"Am J Pathol"},{"key":"R37-12-20210203","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/hmg\/8.4.607","article-title":". Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer.","volume":"8","author":"Richards","year":"1999","journal-title":"Hum Mol Genet"},{"key":"R38-12-20210203","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/carcin\/20.6.1127","article-title":". Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations.","volume":"20","author":"Shinmura","year":"1999","journal-title":"Carcinogenesis"},{"key":"R39-12-20210203","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s100380050137","article-title":". Germline mutations of E-cadherin gene in Korean familial gastric cancer patients.","volume":"44","author":"Yoon","year":"1999","journal-title":"J Hum Genet"},{"key":"R41-12-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10120-009-0531-x","article-title":"Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice.","volume":"13","author":"Guilford","year":"2010","journal-title":"Gastric Cancer"},{"key":"R42-12-20210203","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0955-0674(93)90028-O","article-title":"The structural and functional analysis of cadherin calcium-dependent cell adhesion molecules.","volume":"5","author":"Grunwald","year":"1993","journal-title":"Curr Opin Cell Biol"},{"key":"R43-12-20210203","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/bies.950170203","article-title":"E-cadherin as a tumor (invasion) suppressor gene.","volume":"17","author":"Birchmeier","year":"1995","journal-title":"Bioessays"},{"key":"R44-12-20210203","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/jmg.2009.074237","article-title":". Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.","volume":"47","author":"Fitzgerald","year":"2010","journal-title":"J Med Genet"},{"key":"R45-12-20210203","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/jmg.2004.018275","article-title":". Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.","volume":"41","author":"Brooks-Wilson","year":"2004","journal-title":"J Med Genet"},{"key":"R46-12-20210203","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1038\/sj.onc.1207335","article-title":". Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour.","volume":"23","author":"Oliveira","year":"2004","journal-title":"Oncogene"},{"key":"R47-12-20210203","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1158\/1078-0432.CCR-05-0247","article-title":". Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management.","volume":"11","author":"Suriano","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R48-12-20210203","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1053\/j.gastro.2009.02.065","article-title":". Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression.","volume":"136","author":"Oliveira","year":"2009","journal-title":"Gastroenterology"},{"key":"R49-12-20210203","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1136\/jmg.2003.015594","article-title":". Germline mutations of the E-cadherin (CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients.","volume":"41","author":"Keller","year":"2004","journal-title":"J Med Genet"},{"key":"R50-12-20210203","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1136\/jmg.40.8.e97","article-title":". A novel germline mutation in the MET extracellular domain in a Korean patient with the diffuse type of familial gastric cancer.","volume":"40","author":"Kim","year":"2003","journal-title":"J Med Genet"},{"key":"R51-12-20210203","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.ejca.2004.04.027","article-title":". E-cadherin (CDH1) and p53 rather than SMAD4 and caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.","volume":"40","author":"Oliveira","year":"2004","journal-title":"Eur J Cancer"},{"key":"R52-12-20210203","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/hmg\/ddp046","article-title":". Germline CDH1 deletions in hereditary diffuse gastric cancer families.","volume":"18","author":"Oliveira","year":"2009","journal-title":"Hum Mol Genet"},{"key":"R53-12-20210203","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1053\/gast.2001.29611","article-title":"Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families.","volume":"121","author":"Pharoah","year":"2001","journal-title":"Gastroenterology"},{"key":"R54-12-20210203","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1001\/jama.297.21.2360","article-title":". Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.","volume":"297","author":"Kaurah","year":"2007","journal-title":"JAMA"},{"key":"R55-12-20210203","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10689-007-9172-6","article-title":". Hereditary diffuse gastric cancer: association with lobular breast cancer.","volume":"7","author":"Schrader","year":"2008","journal-title":"Fam Cancer"},{"key":"R56-12-20210203","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D","article-title":". Mutations of the human E-cadherin (CDH1) gene.","volume":"12","author":"Berx","year":"1998","journal-title":"Hum Mutat"},{"key":"R57-12-20210203","first-page":"1919","article-title":". E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain.","volume":"13","author":"Berx","year":"1996","journal-title":"Oncogene"},{"key":"R58-12-20210203","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/jmg.2010.079814","article-title":". Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers.","volume":"48","author":"Schrader","year":"2011","journal-title":"J Med Genet"},{"key":"R59-12-20210203","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/humu.10068","article-title":". Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred.","volume":"19","author":"Oliveira","year":"2002","journal-title":"Hum Mutat"},{"key":"R60-12-20210203","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/jmg.2005.031385","article-title":". Cleft lippalate and CDH1E-cadherin mutations in families with hereditary diffuse gastric cancer.","volume":"43","author":"Frebourg","year":"2006","journal-title":"J Med Genet"},{"key":"R61-12-20210203","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/cncr.23650","article-title":"Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery.","volume":"113","author":"Cisco","year":"2008","journal-title":"Cancer"},{"key":"R62-12-20210203","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1056\/NEJM200106213442504","article-title":". Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.","volume":"344","author":"Huntsman","year":"2001","journal-title":"N Engl J Med"},{"key":"R63-12-20210203","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/01.sla.0000254370.29893.e4","article-title":". CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.","volume":"45","author":"Norton","year":"2007","journal-title":"Ann Surg"},{"key":"R64-12-20210203","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/PAS.0b013e31815e7f1a","article-title":". Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.","volume":"32","author":"Rogers","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R65-12-20210203","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10689-009-9316-y","article-title":". Pregnancy after prophylactic total gastrectomy.","volume":"9","author":"Kaurah","year":"2010","journal-title":"Fam Cancer"},{"key":"R66-12-20210203","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","article-title":". American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"R67-12-20210203","doi-asserted-by":"crossref","first-page":"562","DOI":"10.6004\/jnccn.2010.0043","article-title":". Geneticfamilial high-risk assessment: breast and ovarian.","volume":"8","author":"Daly","year":"2010","journal-title":"J Natl Compr Cancer Netw"},{"key":"R68-12-20210203","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1749-6632.2001.tb04007.x","article-title":"The role of tamoxifen in breast cancer prevention: issues sparked by the NSABP Breast Cancer Prevention Trial (P-1).","volume":"949","author":"Wolmark","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"R69-12-20210203","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/BF02586773","article-title":"The cancer-family syndrome: a pragmatic basis for syndrome identification.","volume":"22","author":"Lynch","year":"1979","journal-title":"Dis Colon Rectum"},{"key":"R70-12-20210203","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/GIM.0b013e31818fa2db","article-title":". EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome.","volume":"11","author":"Palomaki","year":"2009","journal-title":"Genet Med"},{"key":"R71-12-20210203","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/107327480901600103","article-title":"Endometrial cancer and Lynch syndrome: clinical and pathologic considerations.","volume":"16","author":"Meyer","year":"2009","journal-title":"Cancer Control"},{"key":"R72-12-20210203","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/jama.296.12.1479","article-title":". Prediction of germline mutations and cancer risk in the Lynch syndrome.","volume":"296","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"R73-12-20210203","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/(SICI)1097-0215(19971021)74:5<551::AID-IJC13>3.0.CO;2-9","article-title":". Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome.","volume":"74","author":"Aarnio","year":"1997","journal-title":"Int J Cancer"},{"key":"R74-12-20210203","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L","article-title":". Cancer risk in mutation carriers of DNA-mismatch-repair genes.","volume":"81","author":"Aarnio","year":"1999","journal-title":"Int J Cancer"},{"key":"R75-12-20210203","first-page":"2994","article-title":"Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea.","volume":"6","author":"Park","year":"2000","journal-title":"Clin Cancer Res"},{"key":"R76-12-20210203","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1053\/gast.1996.v110.pm8612988","article-title":". Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.","volume":"110","author":"Vasen","year":"1996","journal-title":"Gastroenterology"},{"key":"R77-12-20210203","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ijc.23508","article-title":". The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome.","volume":"123","author":"Watson","year":"2008","journal-title":"Int J Cancer"},{"key":"R78-12-20210203","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1136\/gut.2006.114876","article-title":". Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer A molecular genetic study.","volume":"56","author":"Gylling","year":"2007","journal-title":"Gut"},{"key":"R79-12-20210203","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1093\/jnci\/89.23.1758","article-title":". A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines.","volume":"89","author":"Rodriguez-Bigas","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"R80-12-20210203","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djh034","article-title":". Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.","volume":"96","author":"Umar","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R81-12-20210203","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":". A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"R82-12-20210203","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":". Identification of the breast cancer susceptibility gene BRCA2.","volume":"378","author":"Wooster","year":"1995","journal-title":"Nature"},{"key":"R83-12-20210203","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","article-title":"Cancer risks in BRCA2 mutation carriers.","volume":"91","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R84-12-20210203","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1054\/bjoc.2000.1605","article-title":". The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel.","volume":"84","author":"Figer","year":"2001","journal-title":"Br J Cancer"},{"key":"R85-12-20210203","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/sj.bjc.6600562","article-title":". BRCA2 gene mutations in families with aggregations of breast and stomach cancers.","volume":"87","author":"Jakubowska","year":"2002","journal-title":"Br J Cancer"},{"key":"R86-12-20210203","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/sj.ejhg.5201064","article-title":". A high frequency of BRCA2 gene mutations in Polish families with ovarian and stomach cancer.","volume":"11","author":"Jakubowska","year":"2003","journal-title":"Eur J Hum Genet"},{"key":"R87-12-20210203","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0959-8049(99)00135-5","article-title":". Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers.","volume":"35","author":"Johannsson","year":"1999","journal-title":"Eur J Cancer"},{"key":"R88-12-20210203","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/annonc\/mdh474","article-title":"Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing.","volume":"15","author":"Lorenzo","year":"2004","journal-title":"Ann Oncol"},{"key":"R89-12-20210203","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","article-title":". Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.","volume":"94","author":"Brose","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"R90-12-20210203","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":". Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.","volume":"68","author":"Risch","year":"2001","journal-title":"Am J Hum Genet"},{"key":"R91-12-20210203","first-page":"60","article-title":"BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian.","volume":"7","author":"Friedenson","year":"2005","journal-title":"MedGenMed"},{"key":"R92-12-20210203","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/000313480807400119","article-title":". Gastric adenocarcinoma arising from fundic gland polyps in a patient with familial adenomatous polyposis syndrome.","volume":"74","author":"Garrean","year":"2008","journal-title":"Am Surg"},{"key":"R93-12-20210203","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/0016-5085(92)90322-P","article-title":". The risk of upper gastrointestinal cancer in familial adenomatous polyposis.","volume":"102","author":"Offerhaus","year":"1992","journal-title":"Gastroenterology"},{"key":"R94-12-20210203","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.gastro.2003.07.017","article-title":"Gastric fundic gland polyps.","volume":"125","author":"Burt","year":"2003","journal-title":"Gastroenterology"},{"key":"R95-12-20210203","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10689-010-9352-7","article-title":". FAP, gastric cancer, and genetic counseling featuring children and young adults: a family study and review.","volume":"9","author":"Lynch","year":"2010","journal-title":"Fam Cancer"},{"key":"R96-12-20210203","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/1097-0142(19951215)76:12<2427::AID-CNCR2820761205>3.0.CO;2-B","article-title":". Attenuated familial adenomatous polyposis (AFAP). A phenotypically and genotypically distinctive variant of FAP.","volume":"76","author":"Lynch","year":"1995","journal-title":"Cancer"},{"key":"R97-12-20210203","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0002-9440(10)64588-9","article-title":". Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations.","volume":"157","author":"Abraham","year":"2000","journal-title":"Am J Pathol"},{"key":"R98-12-20210203","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.cgh.2007.11.018","article-title":". Fundic gland polyp dysplasia is common in familial adenomatous polyposis.","volume":"6","author":"Bianchi","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R99-12-20210203","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1200\/JCO.2008.16.7056","article-title":"Total gastrectomy for gastric dysplasia in a patient with attenuated familial adenomatous polyposis syndrome.","volume":"26","author":"Dunn","year":"2008","journal-title":"J Clin Oncol"},{"key":"R100-12-20210203","first-page":"6643","article-title":". Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.","volume":"63","author":"Olivier","year":"2003","journal-title":"Cancer Res"},{"key":"R101-12-20210203","first-page":"747","article-title":"Soft-tissue sarcomas, breast cancer, and other neoplasms.","volume":"71","author":"Li","year":"1969","journal-title":"A familial syndrome Ann Intern Med"},{"key":"R102-12-20210203","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","article-title":". Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.","volume":"250","author":"Malkin","year":"1990","journal-title":"Science"},{"key":"R103-12-20210203","doi-asserted-by":"crossref","first-page":"8287","DOI":"10.1158\/0008-5472.CAN-05-4247","article-title":". Joint effects of germ-line p53 mutation and sex on cancer risk in Li-Fraumeni syndrome.","volume":"66","author":"Wu","year":"2006","journal-title":"Cancer Res"},{"key":"R104-12-20210203","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/jnci\/90.8.606","article-title":". Multiple primary cancers in families with Li-Fraumeni syndrome.","volume":"90","author":"Hisada","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"R105-12-20210203","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/jmg.2008.058958","article-title":". High frequency of de novo mutations in Li-Fraumeni syndrome.","volume":"46","author":"Gonzalez","year":"2009","journal-title":"J Med Genet"},{"key":"R106-12-20210203","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2354.2008.01066.x","article-title":". Familial gastric cancer and Li-Fraumeni syndrome.","volume":"19","author":"Corso","year":"2010","journal-title":"Eur J Cancer Care (Engl)"},{"key":"R107-12-20210203","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/GIM.0b013e31821628b6","article-title":". Gastric cancer in individuals with Li-Fraumeni syndrome.","volume":"13","author":"Masciari","year":"2011","journal-title":"Genet Med"},{"key":"R108-12-20210203","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/jmg.2009.073429","article-title":". TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.","volume":"47","author":"Ruijs","year":"2010","journal-title":"J Med Genet"},{"key":"R109-12-20210203","first-page":"134","article-title":"Very remarkable case of familial polyposis of mucous membrane of intestinal tract and nasopharynx accompanied by peculiar pigmentations of skin and mucous membrane.","volume":"10","author":"Peutz","year":"1921","journal-title":"Nederl Maandschr Geneesk"},{"key":"R110-12-20210203","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM194912292412601","article-title":"Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance.","volume":"241","author":"Jeghers","year":"1949","journal-title":"N Engl J Med"},{"key":"R111-12-20210203","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJM198706113162404","article-title":". Increased risk of cancer in the Peutz-Jeghers syndrome.","volume":"316","author":"Giardiello","year":"1987","journal-title":"N Engl J Med"},{"key":"R112-12-20210203","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1053\/j.gastro.2004.03.014","article-title":". Relative frequency and morphology of cancers in STK11 mutation carriers.","volume":"126","author":"Lim","year":"2004","journal-title":"Gastroenterology"},{"key":"R113-12-20210203","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1053\/gast.2000.20228","article-title":". Very high risk of cancer in familial Peutz-Jeghers syndrome.","volume":"119","author":"Giardiello","year":"2000","journal-title":"Gastroenterology"},{"key":"R114-12-20210203","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/ajg.2009.725","article-title":". High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations.","volume":"105","author":"van Lier","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R115-12-20210203","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/gut.2010.223750","article-title":". High cancer risk and increased mortality in patients with Peutz-Jeghers syndrome.","volume":"60","author":"van Lier","year":"2011","journal-title":"Gut"},{"key":"R116-12-20210203","first-page":"5267","article-title":". Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome.","volume":"58","author":"Gruber","year":"1998","journal-title":"Cancer Res"},{"key":"R117-12-20210203","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1521-6918(02)00149-X","article-title":"Hereditary polyposis syndromes and hereditary non-polyposis colorectal cancer.","volume":"17","author":"Allen","year":"2003","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R118-12-20210203","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0733-8635(18)30575-8","article-title":"Gastrointestinal polyposis syndromes.","volume":"7","author":"Finan","year":"1989","journal-title":"Dermatol Clin"},{"key":"R119-12-20210203","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/jnci\/90.14.1039","article-title":"The concise handbook of family cancer syndromes. Mayo Familial Cancer Program.","volume":"90","author":"Lindor","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"R120-12-20210203","first-page":"71","article-title":". Peutz-Jeghers syndrome: its natural course and management.","volume":"136","author":"Utsunomiya","year":"1975","journal-title":"Johns Hopkins Med J"},{"key":"R121-12-20210203","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/jmg.2004.018598","article-title":". The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations.","volume":"41","author":"Howe","year":"2004","journal-title":"J Med Genet"},{"key":"R122-12-20210203","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/BF02557528","article-title":". Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis.","volume":"9","author":"Sayed","year":"2002","journal-title":"Ann Surg Oncol"},{"key":"R123-12-20210203","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/jmg.2006.041517","article-title":". SMAD4 mutations found in unselected HHT patients.","volume":"43","author":"Gallione","year":"2006","journal-title":"J Med Genet"}],"container-title":["The Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00130404-201207000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,23]],"date-time":"2022-01-23T05:35:50Z","timestamp":1642916150000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130404-201207000-00012"}},"subtitle":["Stomach"],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":122,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ppo.0b013e31826246dc","relation":{},"ISSN":["1528-9117"],"issn-type":[{"value":"1528-9117","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}